跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 57,898 条关于
“Non-Alcoholic Steatohepatitis”
全部
57,898
临床试验
44,905
药物
816
机构
132
资讯
12,045
去年
NASH Treatment Market to Reach Significant Growth by 2032, Driven by Emerging Therapies
去年
Novo Nordisk's Semaglutide Shows Promise in NASH Trials
去年
Madrigal Pharmaceuticals Advances in NASH Treatment with Resmetirom Phase 3 Trials
去年
Can-Fite BioPharma Advances Clinical Trials for Psoriasis, HCC, and NASH
去年
Positive Outlook for Akero Therapeutics Based on Promising Clinical Trial Developments
2年前
FDA Approves Resmetirom (REZDIFFRA™) as First Treatment for NASH
去年
Novo Nordisk's Semaglutide Achieves Primary Endpoint in NASH Trial
12个月前
Genflow Biosciences Files Patent Examination Request in China for SIRT6-Based NASH Therapy
去年
NASH Pipeline Shows Promise with 80+ Emerging Therapies in Development
去年
Morepen Laboratories Advances Development of Resmetirom for NASH Treatment
第 1 页，共 1205 页
上一页
下一页
